Literature DB >> 1110433

Growth rebound after termination of stimulant drugs.

D J Safer, R P Allen, E Barr.   

Abstract

To explore further the report of an accelerated weight gain following termination of treatment with a stimulant drug, 66 biannual growth measurements were obtained from 1970 to 1973 on hyperactive schoolchildren who were receiving medication. All received either dextroamphetamine or methylphenidate during the school year; some also received it during the summer. The data revealed that those whose stimulant medication was terminated at the start of summer subsequently grew in weight and height at a significantly greater rate than those who continued to receive medication from June to September. In fact, discontinuance of the medication resulted in a growth rebound for this period which was 15-68% above the age-expected increment.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1110433     DOI: 10.1016/s0022-3476(75)80720-7

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  17 in total

1.  Attention-deficit/hyperactivity disorder drugs and growth: an Italian prospective observational study.

Authors:  Elena A P Germinario; Romano Arcieri; Maurizio Bonati; Alessandro Zuddas; Gabriele Masi; Stefano Vella; Flavia Chiarotti; Pietro Panei
Journal:  J Child Adolesc Psychopharmacol       Date:  2013-09-11       Impact factor: 2.576

Review 2.  Understanding the risk of using medications for attention deficit hyperactivity disorder with respect to physical growth and cardiovascular function.

Authors:  Benedetto Vitiello
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2008-04

3.  Trajectories of Growth Associated With Long-Term Stimulant Medication in the Multimodal Treatment Study of Attention-Deficit/Hyperactivity Disorder.

Authors:  Laurence L Greenhill; James M Swanson; Lily Hechtman; James Waxmonsky; L Eugene Arnold; Brooke S G Molina; Stephen P Hinshaw; Peter S Jensen; Howard B Abikoff; Timothy Wigal; Annamarie Stehli; Andrea Howard; Michael Hermanussen; Tomasz Hanć
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2019-08-15       Impact factor: 8.829

Review 4.  Growth on stimulant medication; clarifying the confusion: a review.

Authors:  A Poulton
Journal:  Arch Dis Child       Date:  2005-08       Impact factor: 3.791

Review 5.  Use of drugs in child psychiatry.

Authors:  P Sitholey
Journal:  Indian J Pediatr       Date:  1984 Jul-Aug       Impact factor: 1.967

6.  Growth and cardiovascular measures in hyperactive individuals as young adults and in matched normal controls.

Authors:  L Hechtman; G Weiss; T Perlman
Journal:  Can Med Assoc J       Date:  1978-05-20       Impact factor: 8.262

7.  Chronic exposure to methylphenidate impairs appendicular bone quality in young rats.

Authors:  David E Komatsu; Panayotis K Thanos; Michelle N Mary; Haden A Janda; Christine M John; Lisa Robison; Mala Ananth; James M Swanson; Nora D Volkow; Michael Hadjiargyrou
Journal:  Bone       Date:  2012-03-19       Impact factor: 4.398

8.  Pharmacotherapy of ADHD in young children.

Authors:  Brigette S Vaughan; Christopher J Kratochvil
Journal:  Psychiatry (Edgmont)       Date:  2006-08

Review 9.  Long-term use of stimulants in children with attention deficit hyperactivity disorder: safety, efficacy, and long-term outcome.

Authors:  Lily Hechtman; Brian Greenfield
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

10.  Early postnatal exposure to methylphenidate alters stress reactivity and increases hippocampal ectopic granule cells in adult rats.

Authors:  Annelyn Torres-Reveron; Jason D Gray; Jay T Melton; Michael Punsoni; Nora E Tabori; Mary J Ward; Kelly Frys; Costantino Iadecola; Teresa A Milner
Journal:  Brain Res Bull       Date:  2008-12-25       Impact factor: 4.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.